Synthesis and preclinical evaluation of [<sup>11</sup>C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor.

Authors:
Högnäsbacka AA; Poot AJ; Plisson C; Bergare J; Bonsall DR and 11 more

Journal:
EJNMMI Res

Publication Year: 2024

DOI:
10.1186/s13550-024-01078-6

PMCID:
PMC10873260

PMID:
38363422

View on PubMed View on PMC View Publisher
Journal Information

Full Title: EJNMMI Res

Abbreviation: EJNMMI Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Radiology, Nuclear Medicine & Medical Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Dynamic whole-body [<sup>18</sup>F]FES PET/CT increases lesion visibility in patients with metastat…
Pedersen MA; Munk OL; Dias AH and 11 more (2024) - Transparency Score: 4/6
Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell…
de Roest RH; Stigter van Walsum M; van der Schilden K and 1 more (2024) - Transparency Score: 3/6
PSMA imaging as a non-invasive tool to monitor inducible gene expression in vivo.
Simunic M; Joshi JT; Merkens H and 4 more (2024) - Transparency Score: 3/6
Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in pepti…
Persson M; Hindorf C; Ardenfors O and 2 more (2024) - Transparency Score: 3/6
Spherization indices measured by resting SPECT improve risk stratification in patients with ischemi…
Zhao Y; Hu Y; Li Y and 9 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsA.D.W. is editor-in-chief of Nuclear Medicine & Biology. Competing interests A.D.W. is editor-in-chief of Nuclear Medicine & Biology."

Evidence found in paper:

"Funding This project has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska–Curie grant agreement No 675417."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025